{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T01:44:45Z","timestamp":1795052685705,"version":"4.10.2"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,15]],"date-time":"2018-11-15T00:00:00Z","timestamp":1542240000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Avian influenza remains an important zoonotic disease with a significant global impact. The spread of H5 highly pathogenic avian influenza (HPAI) viruses (clade 2.3.4.4) by migratory birds has caused outbreaks in wide geographic regions (Asia, Europe, and North America) with great economic losses during 2014\u20132015. Efficient vaccines and vaccination approaches are needed to enhance protective immunity against HPAI viruses. Although several vaccination strategies have been developed, none has been satisfactory. Our strategy has been to use avirulent vaccine strain of Newcastle disease virus (NDV) as a vaccine vector for HPAI viruses. For poultry vaccination, we previously generated a new platform of chimeric NDV vector to overcome preexisting maternal antibodies to NDV in poultry. In this study, we have generated vaccine candidates targeting H5 clade 2.3.4.4 HPAI viruses by using our chimeric NDV and conventional NDV strain LaSota vectors for a heterologous prime-boost immunization approach. Co-expression of the HA and NA proteins by our vaccine vectors induced enhanced HPAI virus specific immune responses in specific-pathogen free and broiler chickens prior to challenge. Further, these vaccine candidates efficiently protected broiler chickens from mortality, clinical signs, and shedding of homologous and heterologous H5 HPAI viruses and highly virulent NDV, thus providing a dual vaccination approach in the field.<\/jats:p>","DOI":"10.1038\/s41598-018-35337-z","type":"journal-article","created":{"date-parts":[[2018,11,9]],"date-time":"2018-11-09T12:13:19Z","timestamp":1541765599000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Co-expression of the Hemagglutinin and Neuraminidase by Heterologous Newcastle Disease Virus Vectors Protected Chickens against H5 Clade 2.3.4.4 HPAI Viruses"],"prefix":"10.1038","volume":"8","author":[{"given":"Yeonwoo","family":"Cho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barisha","family":"Lamichhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdou","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishita Roy","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siba K.","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4510-4623","authenticated-orcid":false,"given":"Shin-Hee","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,15]]},"reference":[{"key":"35337_CR1","unstructured":"Palese, P. & Shaw, M. L. Orthomyxoviridae: the viruses and their replication. (ed. Knipe, D. M.& Howley, P. M.) 1647\u20131689 Fields Virology (Lippincott Williams & Wilkins, 2007)."},{"key":"35337_CR2","unstructured":"OIE (World Organisation for Animal Health) Avian Influenza, http:\/\/www.oie.int\/fileadmin\/Home\/eng\/Health_standards\/tahm\/2.03.04_AI.pdf (2015)."},{"key":"35337_CR3","doi-asserted-by":"publisher","first-page":"11560","DOI":"10.1128\/JVI.00713-07","volume":"81","author":"JM DiNapoli","year":"2007","unstructured":"DiNapoli, J. M. et al. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. J Virol 81, 11560\u201311568 (2007).","journal-title":"J Virol"},{"key":"35337_CR4","unstructured":"FAO. H7N9 situation update. Available at, http:\/\/www.fao.org\/ag\/againfo\/programmes\/en\/empres\/h7n9\/situation_update.html (2018)."},{"key":"35337_CR5","unstructured":"WHO. 2017 Cumulative number of confirmed human cases of avian influenza A (H5N1) reported to WHO, 2003\u20132017. World Health Organization, Geneva, Switzerland. http:\/\/www.who.int\/influenza\/human_animal_interface\/2017_02_14_tableH5N1.pdf?ua=1."},{"key":"35337_CR6","doi-asserted-by":"crossref","unstructured":"Suarez, D. L. & Pantin-Jackwood, M. J. Recombinant viral-vectored vaccines for the control of avian influenza in poultry. Veterinary MicrobioL, doi.org\/10.1016 (2016)","DOI":"10.1016\/j.vetmic.2016.11.025"},{"key":"35337_CR7","doi-asserted-by":"crossref","unstructured":"The global consortium for h5n8 and related influenza viruses. Role for migratory wild birds in the global spread of avian influenza H5N8. Science, 354, 213\u2013217 (2016).","DOI":"10.1126\/science.aaf8852"},{"key":"35337_CR8","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.virol.2016.04.019","volume":"494","author":"K Bertran","year":"2016","unstructured":"Bertran, K. et al. Lack of chicken adaptation of newly emergent Eurasian H5N8 and reassortant H5N2 high pathogenicity avian influenza viruses in the U.S. is consistent with restricted poultry outbreaks in the Pacific flyway during 2014\u20132015. Virology 494, 190\u2013197 (2016).","journal-title":"Virology"},{"key":"35337_CR9","doi-asserted-by":"publisher","first-page":"886","DOI":"10.3201\/eid2105.142020","volume":"21","author":"HS Ip","year":"2015","unstructured":"Ip, H. S. et al. Novel Eurasian highly pathogenic avian influenza A H5 viruses in wild birds, Washington, USA, 2014. Emerg Infect Dis 21, 886\u2013890 (2015).","journal-title":"Emerg Infect Dis"},{"key":"35337_CR10","first-page":"111","volume":"64","author":"MA Jhung","year":"2015","unstructured":"Jhung, M. A. & Nelson, D. I. Centers for Disease Control and Prevention (CDC). Outbreaks of avian influenza A H5N2, H5N8, and H5N1 among birds \u2013 United States, December 2014\u2013January 2015. Morb Mortal Wkly Rep 64, 111 (2015).","journal-title":"Morb Mortal Wkly Rep"},{"key":"35337_CR11","unstructured":"United States Department of Agriculture, Animal and Plant Health Inspection Service, Highly Pathogenic Avian Influenza Infected Premises 2014\u20132015, https:\/\/www.aphis.usda.gov\/animal_health\/animal_dis_spec\/poultry\/downloads\/hpai-positive-premises-2014-2015.pdf (2015)."},{"key":"35337_CR12","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3201\/eid2207.160048","volume":"22","author":"DH Lee","year":"2016","unstructured":"Lee, D. H. et al. Highly pathogenic avian influenza viruses and generation of novel reassortants, United States, 2014\u20132015. Emerg Inf Dis 22, 1283\u20131285 (2016).","journal-title":"Emerg Inf Dis"},{"key":"35337_CR13","doi-asserted-by":"publisher","first-page":"e00195","DOI":"10.1128\/genomeA.00195-15","volume":"3","author":"MK Torchetti","year":"2015","unstructured":"Torchetti, M. K. et al. Novel H5 Clade 2.3.4.4 Reassortant (H5N1) Virus from a Green-Winged Teal in Washington, USA. Genome Announc 3, e00195\u201300115 (2015).","journal-title":"Genome Announc"},{"key":"35337_CR14","unstructured":"United States Department of Agriculture, Food Safety and Inspection Service. Export library \u2013 Requirements by Country, http:\/\/www.fsis.usda.gov\/wps\/portal\/fsis\/topics\/international-affairs\/exporting-products\/export-library-requirements-by-country (2015)."},{"key":"35337_CR15","doi-asserted-by":"publisher","first-page":"8203","DOI":"10.1073\/pnas.0602566103","volume":"103","author":"MS Park","year":"2006","unstructured":"Park, M. S. et al. Engineered viral vaccine constructs with dual specificity: avian influenza and Newcastle disease. Proc Natl Acad Sci USA 103, 8203\u20138208 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35337_CR16","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1073\/pnas.1012457108","volume":"108","author":"MF Ducatez","year":"2011","unstructured":"Ducatez, M. F. et al. Feasibility of reconstructed ancestral H5N1 influenza viruses for cross-clade protective vaccine development. Proc Natl Acad Sci USA 108, 349\u2013354 (2011).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35337_CR17","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.vetmic.2010.12.016","volume":"150","author":"EM Kilany","year":"2011","unstructured":"Kilany, E. M. et al. Protective efficacy of H5 inactivated vaccines in meat turkey poults after challenge with Egyptian variant highly pathogenic avian influenza H5N1 virus. Vet Microbiol 150, 28\u201334 (2011).","journal-title":"Vet Microbiol"},{"key":"35337_CR18","unstructured":"Swayne, D. E. Avian influenza vaccine use during 2001. 469\u2013471, Proceedings of the 104th annual meeting of the U.S. Animal Health Association, USAHA, Richmond, VA, USA (2001)."},{"key":"35337_CR19","first-page":"79","volume":"135","author":"DE Swayne","year":"2013","unstructured":"Swayne, D. E. & Spackman, E. Current status and future needs in diagnosis and vaccines for high pathogenicity avian influenza. Avian influenza diagnostics and vaccines 135, 79\u201394 (2013).","journal-title":"Avian influenza diagnostics and vaccines"},{"key":"35337_CR20","doi-asserted-by":"publisher","first-page":"6336","DOI":"10.1016\/j.vaccine.2017.05.051","volume":"35","author":"K Bertran","year":"2017","unstructured":"Bertran, K. et al. Protection of white leghorn chickens by U.S. emergency H5 vaccination against clade 2.3.4.4 H5N2 high pathogenicity avian influenza virus. Vaccine 35, 6336\u20136344 (2017).","journal-title":"Vaccine"},{"key":"35337_CR21","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.virol.2017.01.006","volume":"503","author":"SH Kim","year":"2017","unstructured":"Kim, S. H., Paldurai, A. & Samal, S. K. A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus. Virology 503, 31\u201336 (2017).","journal-title":"Virology"},{"key":"35337_CR22","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1016\/j.vaccine.2017.06.055","volume":"35","author":"SH Kim","year":"2017","unstructured":"Kim, S. H. & Samal, S. K. Heterologous prime-boost immunization of Newcastle disease virus vectored vaccines protected broiler chickens against highly pathogenic avian influenza and Newcastle disease viruses. Vaccine 35, 4133\u20134139 (2017).","journal-title":"Vaccine"},{"key":"35337_CR23","doi-asserted-by":"publisher","first-page":"10293","DOI":"10.1128\/JVI.00919-06","volume":"80","author":"A Bukreyev","year":"2006","unstructured":"Bukreyev, A., Skiadopoulos, M. H., Murphy, B. R. & Collins, P. L. Nonsegmented negative-strand viruses as vaccine vectors. J Virol 80, 10293\u201310306 (2006).","journal-title":"J Virol"},{"key":"35337_CR24","first-page":"38","volume":"53","author":"MC Eichelberger","year":"2018","unstructured":"Eichelberger, M. C., Morens, D. M. & Taubenberger, J. K. Neuraminidase as an influenza vaccine antigen: a low hanging fruit, ready for picking to improve vaccine effectiveness. Current Opinin. Immunol 53, 38\u201344 (2018).","journal-title":"Immunol"},{"key":"35337_CR25","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1128\/JVI.01946-09","volume":"84","author":"JM DiNapoli","year":"2010","unstructured":"DiNapoli, J. M. et al. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. J Virol 84, 1489\u20131503 (2010).","journal-title":"J Virol"},{"key":"35337_CR26","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1128\/JVI.01514-06","volume":"81","author":"J Ge","year":"2007","unstructured":"Ge, J. et al. Newcastle disease virus-based live attenuated vaccine completely protects chickens and mice from lethal challenge of homologous and heterologous H5N1 avian influenza viruses. J Virol 81, 150\u2013158 (2007).","journal-title":"J Virol"},{"key":"35337_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/v8070183","volume":"8","author":"SH Kim","year":"2016","unstructured":"Kim, S. H. & Samal, S. K. Newcastle disease virus as a vaccine vector for development of human and veterinary vaccines. Viruses 8, 183 (2016).","journal-title":"Viruses"},{"key":"35337_CR28","doi-asserted-by":"publisher","first-page":"e6509","DOI":"10.1371\/journal.pone.0006509","volume":"4","author":"B Nayak","year":"2009","unstructured":"Nayak, B. et al. Immunization of chickens with Newcastle disease virus expressing H5 hemagglutinin protects against highly pathogenic H5N1 avian influenza viruses. PLoS ONE 4, e6509 (2009).","journal-title":"PLoS ONE"},{"key":"35337_CR29","doi-asserted-by":"publisher","first-page":"2408","DOI":"10.1128\/JVI.02135-09","volume":"84","author":"B Nayak","year":"2010","unstructured":"Nayak, B. et al. Contributions of the avian influenza virus HA, NA, and M2 surface proteins to the induction of neutralizing antibodies and protective immunity. J Virol 84, 2408\u20132420 (2010).","journal-title":"J Virol"},{"key":"35337_CR30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1637\/0005-2086-47.s3.1047","volume":"47","author":"DE Swayne","year":"2003","unstructured":"Swayne, D. E. et al. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Dis 47, 1047\u20131050 (2003).","journal-title":"Avian Dis"},{"key":"35337_CR31","doi-asserted-by":"publisher","first-page":"8197","DOI":"10.1073\/pnas.0602461103","volume":"103","author":"J Veits","year":"2006","unstructured":"Veits, J. et al. Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza. Proc Natl Acad Sci USA 103, 8197\u20138202 (2006).","journal-title":"Proc Natl Acad Sci USA"},{"key":"35337_CR32","first-page":"153","volume":"333","author":"H Chen","year":"2009","unstructured":"Chen, H. & Bu, Z. Development and application of avian influenza vaccines in China. Curr Top Microbiol Immunol 333, 153\u2013162 (2009).","journal-title":"Curr Top Microbiol Immunol"},{"key":"35337_CR33","doi-asserted-by":"publisher","first-page":"261","DOI":"10.20506\/rst.28.1.1877","volume":"28","author":"C Villarreal","year":"2009","unstructured":"Villarreal, C. Avian influenza in Mexico. Revue Scientifique et Technique 28, 261\u2013265 (2009).","journal-title":"Revue Scientifique et Technique"},{"key":"35337_CR34","doi-asserted-by":"publisher","first-page":"e00417","DOI":"10.1128\/mBio.00417-16","volume":"7","author":"MJ Memoli","year":"2016","unstructured":"Memoli, M. J. et al. Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model. MBio 7, e00417\u201300416 (2016).","journal-title":"MBio"},{"key":"35337_CR35","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1637\/10183-041012-Review.1","volume":"56","author":"DE Swayne","year":"2012","unstructured":"Swayne, D. E. Impact of vaccines and vaccination on global control of avian influenza. Avian Dis 56, 818\u2013828 (2012).","journal-title":"Avian Dis"},{"issue":"11","key":"35337_CR36","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.3201\/eid2311.171013","volume":"23","author":"Dong-Hun Lee","year":"2017","unstructured":"Lee, D. H., et al. Highly pathogenic avian influenza A(H7N9) virus, Tennessee, USA, March 2017. Emerg Infect Dis 23, 1860\u20131863 (2017).","journal-title":"Emerging Infectious Diseases"},{"key":"35337_CR37","doi-asserted-by":"publisher","first-page":"18.5.1","DOI":"10.1002\/cpmc.44","volume":"48","author":"SH Kim","year":"2018","unstructured":"Kim, S. H. & Samal, S. K. Reverse genetics for Newcastle disease virus as a vaccine vector. Current Protocols Microbiol 48, 18.5.1\u201318.5.12, https:\/\/doi.org\/10.1002\/cpmc.44 (2018).","journal-title":"Current Protocols Microbiol"},{"key":"35337_CR38","unstructured":"Alexander, D. J. Newcastle disease and other avian paramyxoviruses. A laboratory manual for the isolation and identification of avian pathogens. American Association of Avian Pathologists, 156\u2013163 (1998)."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35337-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35337-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T11:36:11Z","timestamp":1671622571000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35337-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35337"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35337-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,15]]},"assertion":[{"value":"1 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"16854"}}